Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Net Debt history
Currency unavailable · from the balance sheet
No Net Debt data reported for this period type.
Net Debt vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $539.41M USD | -27.9% | +8.8% | 32.7% | |
| Mar 2026 | $266.87M USD | -24.4% | -23.4% | 22.1% | |
| Mar 2026 | $103.01M USD | +188.5% | — | 35.1% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | -24.4% | -7.3% | 32.7% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.